Start-Up Previews (06/2009)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Start-Ups Set Sights on Flu," features profiles of Alios BioPharma, Immune Targeting Systems, Marinomed Biotechnologie and Vivaldi Biosciences. Plus these Start-Ups Across Health Care: CardiAQ Valve Technologies, NKT THerapeutics, SPOC Inc.,and Sutro Biopharma.

Alios BioPharma Inc. Also see "Alios BioPharma Inc." - Scrip, 1 June, 2009. aims to create an improved version of interferon—the only drug that could be considered a broad-spectrum antiviral—to help patients who do not respond well to currently marketed forms of the protein. Alios also plans to develop a small-molecule drug that can be given orally yet carry out a key function of the interferon response—degrading viral genomes. Such a drug could potentially treat influenza, hepatitis C and B, HIV, and a host of other viruses.

Immune Targeting Systems Ltd. Also see "Immune Targeting Systems Ltd." - Scrip, 1 June, 2009. is developing synthetic...

More from Archive

More from In Vivo